You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】阿里破頂 資金追好倉 中移動升2%創一個月高位 阿里購13862/ 中移購13697 沽22475/ 港交牛64874 熊52869
阿思達克 12-20 10:36

市場認為參議院通過對美國總統特朗普彈劾法案機會微,美股隔晚再創收市新高。道指收報28376點,升137點(或0.5%)。

恆指昨最多跌208點,低見27675點,收市報27800點,跌83點(或0.3%)。今早好淡爭持,其後升近150點,重上27900點之上。恆指好倉(牛證及認購權證)昨淨流入10萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾660萬元,反映投資者續對後市好淡分歧。昨日恆指牛證街貨重貨區為收回價26400至26499點,而熊證街貨重貨區為收回價28000至28099點。

聯交所披露資料顯示,港交所(00388)行政總裁李小加星期三在場內以每股平均價256.53元,出售65萬股港交所股份,套現1.67億元,為其上任以來首次出售持股。減持股份後,李小加持股量降至0.03%,較前跌0.05%。港交所今早股價變動不大,於255元附近徘徊。

阿里巴巴(09988)升逾1%,曾言見207.4元,創本港第二上市後新高。昨日有近440萬元淨流入其好倉。

中移動(00941)管理層指明年將打造超過100款5G手機,總銷量目標超過1億部。中移動昨逆市拾級而上,以全日高位62.45元收市,升幅0.56%。早前弱勢的中移動,踏入十二月後穩步向上,至昨日累升5.8%,期間僅一個交易日下跌。今早繼續向上,創一個月高位63.6元,突破50天線(62.6元),並挑戰100天線(約64元)。昨有10萬元淨流出其好倉,淡倉同日則有11萬元淨流入。

英倫銀行維持基準利率0.75厘不變,匯控(00005)在英國大選後股價維持高企,昨好淡爭持,微升收市,盤中高見61元,逼近250天線阻力。匯控今早續於60元之上爭持。昨分別有89萬元和30萬元淨流入其好倉和淡倉。

瑞聲(02018)昨先升後回,曾挫逾4%至64.8元,其後獲資金承接,跌幅收窄至2.4%收市,報66元,14天RSI從超買區回落。股份近期呈強,高位整固兩日後,月內仍維持兩成升幅。瑞聲今早在66元水平靠穩,高位上試67元,下方留意會否考驗10天線(約65.1元)支持。昨有逾270萬元淨流入其好倉,淡倉同日則有21萬元淨流出。

醫藥股早前受帶量採購名單拖累,近期則因恆生指數公司推出生物科技指數而稍為帶起板塊。石藥(01093)股價有見底回升跡象,昨守穩18元之上,收升0.66%於18.2元,盤中曾升穿20天線(18.24元)。今早續於18元之上靠穩。昨有10萬元淨流出其好倉,淡倉同日則有28萬元淨流入。

瑞通相關認股證之選擇:

阿里輕微價外、中年期購13862,行使價:228.8元,2020年6月到期,實際槓桿:6.2倍

中移輕微價外、中短期購13697,行使價:68.68元,2020年5月到期,實際槓桿:13.6倍

中移貼價、短期沽22475,行使價:60.88元,2020年3月到期,實際槓桿:12.9倍

匯豐輕微價外、中年期購29822,行使價:63.8元,2020年7月到期,實際槓桿:11.8倍

匯豐輕微價外、中短期沽22469,行使價:55元,2020年3月到期,實際槓桿:17.6倍

瑞聲輕微價外、中年期購13589,行使價:72.8元,2020年6月到期,實際槓桿:4.3倍

美團輕微價外、中短期沽11831,行使價:90元,2020年4月到期,實際槓桿:6.5倍

石藥輕微價外、短期購25482,行使價:19.8元,2020年3月到期,實際槓桿:7.8倍

石藥價外、中年期沽28344,行使價:14.68元,2020年7月到期,實際槓桿:4.2倍

中海貼價、短期購24077,行使價:30.93元,2020年2月到期,實際槓桿:11.9倍

瑞通相關牛熊證之選擇:

恆指牛證66122,收回價:27010點,槓桿比率:26.6倍

恆指N類熊證51908,收回價:28480點,槓桿比率:42.9倍

港交牛證64874,收回價:238.8元,槓桿比率:12.4倍

港交熊證52869,收回價:262.9元,槓桿比率:23.4倍

瑞聲熊證68088,收回價:70元,槓桿比率:6.9倍

石藥牛證63136,收回價:16.2元,槓桿比率:6.2倍

石藥熊證63134,收回價:19.3元,槓桿比率:9.3倍重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account